BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

972 related articles for article (PubMed ID: 26748470)

  • 1. Patients with large-duct primary sclerosing cholangitis and Crohn's disease have a better outcome than those with ulcerative colitis, or without IBD.
    Fevery J; Van Steenbergen W; Van Pelt J; Laleman W; Hoffman I; Geboes K; Vermeire S; Nevens F
    Aliment Pharmacol Ther; 2016 Mar; 43(5):612-20. PubMed ID: 26748470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
    Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
    Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up.
    Fraga M; Fournier N; Safroneeva E; Pittet V; Godat S; Straumann A; Nydegger A; Vavricka SR; Moradpour D; Schoepfer AM;
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):91-97. PubMed ID: 27622999
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inflammatory bowel disease with primary sclerosing cholangitis: A Danish population-based cohort study 1977-2011.
    Sørensen JØ; Nielsen OH; Andersson M; Ainsworth MA; Ytting H; Bélard E; Jess T
    Liver Int; 2018 Mar; 38(3):532-541. PubMed ID: 28796371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of inflammatory bowel disease among patients with primary sclerosing cholangitis in Iran.
    Hadizadeh M; Abedi SH; Malekpour H; Radinnia E; Jabbehdari S; Padashi M; Zali MR; Mohammad Alizadeh AH
    Arab J Gastroenterol; 2016 Mar; 17(1):17-9. PubMed ID: 27032493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey.
    Parlak E; Kosar Y; Ulker A; Dagli U; Alkim C; Sahin B
    J Clin Gastroenterol; 2001 Oct; 33(4):299-301. PubMed ID: 11588543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary sclerosing cholangitis associated with inflammatory bowel disease: an observational study in a Southern Europe population focusing on new therapeutic options.
    Franceschet I; Cazzagon N; Del Ross T; D'Incà R; Buja A; Floreani A
    Eur J Gastroenterol Hepatol; 2016 May; 28(5):508-13. PubMed ID: 26872110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical profile and outcome of primary sclerosing cholangitis: A single-centre experience from western India.
    Tibdewal P; Bhatt P; Jain A; Gupta D; Bhatia S; Shukla A
    Indian J Gastroenterol; 2019 Aug; 38(4):295-302. PubMed ID: 31515764
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CLINICAL AND MORPHOLOGICAL CHARACTERISTICS OF INTESTINAL LESIONS IN PATIENTS WITH PRIMARY SCLEROSING CHOLANGITIS].
    Pazenco EV; Karev VE; Raikhelson KL; Shchukina OB; Botina AV; Kharitonov AG; Semenov NV
    Eksp Klin Gastroenterol; 2016; (7):18-24. PubMed ID: 30284417
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn's disease.
    Rasmussen HH; Fallingborg JF; Mortensen PB; Vyberg M; Tage-Jensen U; Rasmussen SN
    Scand J Gastroenterol; 1997 Jun; 32(6):604-10. PubMed ID: 9200295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A unique clinical phenotype of primary sclerosing cholangitis associated with Crohn's disease.
    Halliday JS; Djordjevic J; Lust M; Culver EL; Braden B; Travis SP; Chapman RW
    J Crohns Colitis; 2012 Mar; 6(2):174-81. PubMed ID: 22325171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical aspects and prognosis of patients with inflammatory bowel disease associated with autoimmune liver diseases.
    Rocha HC; Vilela EG
    Gastroenterol Hepatol; 2022 Feb; 45(2):83-90. PubMed ID: 34023469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Natural History of Primary Sclerosing Cholangitis in Children: A Large Single-Center Longitudinal Cohort Study.
    Valentino PL; Wiggins S; Harney S; Raza R; Lee CK; Jonas MM
    J Pediatr Gastroenterol Nutr; 2016 Dec; 63(6):603-609. PubMed ID: 27504812
    [TBL] [Abstract][Full Text] [Related]  

  • 14. What is the association of primary sclerosing cholangitis with sex and inflammatory bowel disease in Turkish patients?
    Bayraktar Y; Arslan S; Saglam F; Uzunalimoglu B; Kayhan B
    Hepatogastroenterology; 1998; 45(24):2064-72. PubMed ID: 9951867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis.
    Barberio B; Massimi D; Cazzagon N; Zingone F; Ford AC; Savarino EV
    Gastroenterology; 2021 Dec; 161(6):1865-1877. PubMed ID: 34425093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary sclerosing cholangitis associated with inflammatory bowel disease: an update.
    Rossi RE; Conte D; Massironi S
    Eur J Gastroenterol Hepatol; 2016 Feb; 28(2):123-31. PubMed ID: 26636407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary sclerosing cholangitis associated colitis: Characterization of clinical, histologic features, and their associations with liver transplantation.
    Aranake-Chrisinger J; Dassopoulos T; Yan Y; Nalbantoglu I
    World J Gastroenterol; 2020 Jul; 26(28):4126-4139. PubMed ID: 32821074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease.
    Boonstra K; van Erpecum KJ; van Nieuwkerk KM; Drenth JP; Poen AC; Witteman BJ; Tuynman HA; Beuers U; Ponsioen CY
    Inflamm Bowel Dis; 2012 Dec; 18(12):2270-6. PubMed ID: 22407885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region).
    Rönnblom A; Holmström T; Tanghöj H; Rorsman F; Sjöberg D
    J Gastroenterol Hepatol; 2015 Aug; 30(8):1288-92. PubMed ID: 25777994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis.
    de Vries AB; Janse M; Blokzijl H; Weersma RK
    World J Gastroenterol; 2015 Feb; 21(6):1956-71. PubMed ID: 25684965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 49.